perphenazine has been researched along with Dyskinesia, Medication-Induced in 30 studies
Perphenazine: An antipsychotic phenothiazine derivative with actions and uses similar to those of CHLORPROMAZINE.
perphenazine : A phenothiazine derivative in which the phenothiazine tricycle carries a chloro substituent at the 2-position and a 3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl group at N-10.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 74-year-old woman developed a slowly progressive hemichorea starting 3 weeks after discontinuation of low-dose amitriptyline and perphenazine." | 7.67 | A case of progressive hemichorea responsive to high-dose reserpine. ( Friedman, JH, 1986) |
| "A 74-year-old woman developed a slowly progressive hemichorea starting 3 weeks after discontinuation of low-dose amitriptyline and perphenazine." | 3.67 | A case of progressive hemichorea responsive to high-dose reserpine. ( Friedman, JH, 1986) |
| " Dopaminergic and serotonergic pathways are involved in the therapeutic and adverse effects of the drug." | 2.73 | Serotonin and dopamine receptor gene polymorphisms and the risk of extrapyramidal side effects in perphenazine-treated schizophrenic patients. ( Dahl, ML; Gunes, A; Jaanson, P; Scordo, MG, 2007) |
| "Perphenazine was not significantly different in overall effectiveness, compared with quetiapine, risperidone, and ziprasidone." | 2.73 | What CATIE found: results from the schizophrenia trial. ( Davis, SM; Hsiao, JK; Keefe, RS; Lieberman, JA; McEvoy, JP; Rosenheck, RA; Stroup, TS; Swartz, MS, 2008) |
| " This study demonstrates that PD is a safe and effective remedy for maintenance therapy in psychotic patients." | 2.66 | Long-term depot neuroleptic treatment with perphenazine decanoate. I. Efficacy and side effects in a 12 month study of 42 drug monitored psychotic patients. ( Hansen, LB; Højholdt, K; Knudsen, P; Larsen, NE, 1985) |
| " We describe a case of acute dystonia with atypical onset without relation to changes in dosage and with laryngeal involvement with aphonia, but without dyspnoea." | 1.30 | [Atypical acute dystonia]. ( Mors, NP; Nielsen, AS, 1998) |
| "Haloperidol was implicated in 47 patients (37%), followed by amitriptyline/perphenazine in 30%, thioridazine in 27%, and chlorpromazine in 20%." | 1.28 | Neurologic approach to drug-induced movement disorders: a study of 125 patients. ( Jankovic, J; Miller, LG, 1990) |
| " Moreover pharmacokinetic data increasingly have been clinically applied." | 1.27 | Chemotherapy with neuroleptics. Clinical and pharmacokinetic aspects with a particular view to depot preparations. ( Knudsen, P, 1985) |
| "It can sometimes be a cause of orofacial pain." | 1.27 | Tardive dyskinesia: an unrecognized cause of orofacial pain. ( Bassett, A; Blasberg, B; Remick, RA, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (46.67) | 18.7374 |
| 1990's | 6 (20.00) | 18.2507 |
| 2000's | 9 (30.00) | 29.6817 |
| 2010's | 1 (3.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nudelman, A | 1 |
| Gil-Ad, I | 2 |
| Shpaisman, N | 1 |
| Terasenko, I | 1 |
| Ron, H | 1 |
| Savitsky, K | 1 |
| Geffen, Y | 1 |
| Weizman, A | 2 |
| Rephaeli, A | 1 |
| Khouzam, HR | 1 |
| Fusar-Poli, RR | 1 |
| Kraemer, HC | 1 |
| Glick, ID | 1 |
| Klein, DF | 1 |
| Haddad, P | 1 |
| Dursun, SM | 1 |
| Gunes, A | 1 |
| Scordo, MG | 1 |
| Jaanson, P | 1 |
| Dahl, ML | 1 |
| Kenney, C | 1 |
| Hunter, C | 1 |
| Davidson, A | 1 |
| Jankovic, J | 2 |
| Castrioto, A | 1 |
| Tambasco, N | 1 |
| Rossi, A | 1 |
| Calabresi, P | 1 |
| Swartz, MS | 1 |
| Stroup, TS | 1 |
| McEvoy, JP | 1 |
| Davis, SM | 1 |
| Rosenheck, RA | 1 |
| Keefe, RS | 1 |
| Hsiao, JK | 1 |
| Lieberman, JA | 1 |
| DeVeaugh-Geiss, J | 1 |
| Linnoila, M | 1 |
| George, L | 1 |
| Guthrie, S | 1 |
| Larsen, EB | 1 |
| Gerlach, J | 2 |
| Sweet, RA | 1 |
| Pollock, BG | 1 |
| Mulsant, BH | 1 |
| Rosen, J | 1 |
| Lo, KH | 1 |
| Yao, JK | 1 |
| Henteleff, RA | 1 |
| Mazumdar, S | 1 |
| Lauerma, H | 1 |
| Tuliharju, M | 1 |
| Mazure, CM | 1 |
| Nelson, JC | 1 |
| Jatlow, PI | 1 |
| Bowers, MB | 1 |
| Nielsen, AS | 1 |
| Mors, NP | 1 |
| Shtaif, B | 1 |
| Shiloh, R | 1 |
| Rosin, AJ | 1 |
| Fog, R | 1 |
| Pakkenberg, H | 1 |
| Juul, P | 1 |
| Bock, E | 1 |
| Jorgensen, OS | 1 |
| Andersen, J | 1 |
| Miller, LG | 1 |
| Knudsen, P | 3 |
| Galdi, J | 1 |
| Bonato, RR | 1 |
| Povlsen, UJ | 1 |
| Noring, U | 1 |
| Meidahl, B | 1 |
| Korsgaard, S | 1 |
| Waehrens, J | 1 |
| Sachdev, P | 1 |
| Bassett, A | 1 |
| Remick, RA | 1 |
| Blasberg, B | 1 |
| Sandyk, R | 1 |
| Consroe, PF | 1 |
| Iacono, RP | 1 |
| Hansen, LB | 2 |
| Højholdt, K | 2 |
| Larsen, NE | 2 |
| Friedman, JH | 1 |
2 reviews available for perphenazine and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Identification and management of tardive dyskinesia: A case series and literature review.
Topics: Adult; Aged; Anti-Dyskinesia Agents; Clonazepam; Diagnosis, Differential; Dopamine Antagonists; Dysk | 2015 |
Clinical trials design lessons from the CATIE study.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Dyskinesia, Dru | 2009 |
7 trials available for perphenazine and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Serotonin and dopamine receptor gene polymorphisms and the risk of extrapyramidal side effects in perphenazine-treated schizophrenic patients.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Dopamine Antagonists; Dyskinesia, Drug-Induced; Femal | 2007 |
What CATIE found: results from the schizophrenia trial.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Cost-Benefit Analysis; Dibenzothiaze | 2008 |
Association of plasma homovanillic acid with behavioral symptoms in patients diagnosed with dementia: a preliminary report.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Behavior; Dyskinesia, Drug-Induced | 1997 |
Effect of different neuroleptics in tardive dyskinesia and parkinsonism. A video-controlled multicenter study with chlorprothixene, perphenazine, haloperidol and haloperidol + biperiden. Nordic Dyskinesia Study Group.
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Biperiden; Chlorprothixene; Dyskinesia, Drug-I | 1986 |
Relationship of adverse drug reactions to length of hospital-stay in genetically subgrouped schizophrenics.
Topics: Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Depressive Disorder; Double-Blind Me | 1988 |
[The effects of neuroleptics on tardive dyskinesias. A video-controlled, randomized study of chlorprothixene, perphenazine, haloperidol and haloperidol + biperiden].
Topics: Aged; Biperiden; Chlorprothixene; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Female; Halope | 1987 |
Long-term depot neuroleptic treatment with perphenazine decanoate. I. Efficacy and side effects in a 12 month study of 42 drug monitored psychotic patients.
Topics: Adult; Clinical Trials as Topic; Delayed-Action Preparations; Dose-Response Relationship, Drug; Dysk | 1985 |
21 other studies available for perphenazine and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
A mutual prodrug ester of GABA and perphenazine exhibits antischizophrenic efficacy with diminished extrapyramidal effects.
Topics: Administration, Oral; Animals; Antipsychotic Agents; Biological Availability; Catalepsy; Dextroamphe | 2008 |
Clinical experiences and clinical trials.
Topics: Antipsychotic Agents; Benzodiazepines; Chronic Disease; Dyskinesia, Drug-Induced; Humans; Olanzapine | 2008 |
Selecting antipsychotics in schizophrenia: lessons from CATIE.
Topics: Acute Disease; Antipsychotic Agents; Benzodiazepines; Clinical Trials, Phase I as Topic; Dose-Respon | 2006 |
Metoclopramide, an increasingly recognized cause of tardive dyskinesia.
Topics: Adverse Drug Reaction Reporting Systems; Aged; Amitriptyline; Dyskinesia, Drug-Induced; Haloperidol; | 2008 |
Acute dystonia induced by the combination of midodrine and perphenazine.
Topics: Acute Disease; Adrenergic alpha-1 Receptor Agonists; Antipsychotic Agents; Cytochrome P-450 CYP2D6; | 2008 |
Tardive Tourette syndrome.
Topics: Aged; Antipsychotic Agents; Chlorpromazine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Hum | 1980 |
Interaction between antidepressants and perphenazine in psychiatric inpatients.
Topics: Adult; Amitriptyline; Depressive Disorder; Dose-Response Relationship, Drug; Drug Interactions; Drug | 1982 |
Subjective experience of treatment, side-effects, mental state and quality of life in chronic schizophrenic out-patients treated with depot neuroleptics.
Topics: Adult; Aged; Antipsychotic Agents; Chronic Disease; Clopenthixol; Delayed-Action Preparations; Dyski | 1996 |
Neurological motor disorders experienced as religious phenomena: role of abnormal movement monitoring.
Topics: Aged; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Humans; Perphenazine; Psychomotor Diso | 1998 |
Acute neuroleptic treatment in elderly patients without dementia.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Chromatography, High Pressure Liquid; Dose-Response R | 1998 |
[Atypical acute dystonia].
Topics: Acute Disease; Adult; Antipsychotic Agents; Aphonia; Dyskinesia, Drug-Induced; Dystonia; Humans; Mal | 1998 |
Evaluation of the neurotoxic activity of typical and atypical neuroleptics: relevance to iatrogenic extrapyramidal symptoms.
Topics: Animals; Antipsychotic Agents; Basal Ganglia Diseases; Brain; Cell Cycle; Cell Survival; Clozapine; | 2001 |
Treatment of dyskinetic and choreatic movement disorders in adults.
Topics: Adult; Aged; Athetosis; Chorea; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskine | 1978 |
High-dose treatment of rats with perphenazine enanthate.
Topics: Animals; Basal Ganglia; Cell Count; Cerebral Cortex; Corpus Striatum; Dyskinesia, Drug-Induced; Nerv | 1976 |
Neurologic approach to drug-induced movement disorders: a study of 125 patients.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amitriptyline; Antipsychotic Agents; Chorea | 1990 |
Chemotherapy with neuroleptics. Clinical and pharmacokinetic aspects with a particular view to depot preparations.
Topics: Administration, Oral; Antipsychotic Agents; Clopenthixol; Delayed-Action Preparations; Dose-Response | 1985 |
Combined antidepressant-antipsychotic drug preparations.
Topics: Amitriptyline; Drug Combinations; Dyskinesia, Drug-Induced; Humans; Male; Middle Aged; Perphenazine | 1988 |
Tardive dyskinesia: an unrecognized cause of orofacial pain.
Topics: Dyskinesia, Drug-Induced; Facial Pain; Female; Humans; Methotrimeprazine; Middle Aged; Perphenazine | 1986 |
L-tryptophan in drug-induced movement disorders with insomnia.
Topics: Aged; Amitriptyline; Dyskinesia, Drug-Induced; Female; Humans; Perphenazine; Sleep Initiation and Ma | 1986 |
Long-term depot neuroleptic treatment with perphenazine decanoate. II. Different depot intervals in the last 6 months of a 12 month study of 42 drug monitored psychotic patients.
Topics: Adult; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; | 1985 |
A case of progressive hemichorea responsive to high-dose reserpine.
Topics: Aged; Amitriptyline; Chorea; Dyskinesia, Drug-Induced; Female; Humans; Perphenazine; Reserpine; Subs | 1986 |